75 Recruiting Neuroblastoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Neuroblastoma
Related Conditions
Top Recruiting Neuroblastoma Studies
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Neuroblastoma Precision Trial
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Neuroblastoma Maintenance Therapy Trial
📍 University of Alabama, Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
📍 Riley Hospital for Children — Indianapolis, Indiana
View Study & Checklist ➔A Study of N9 Chemotherapy in Children With Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
📍 UCSF Medical Center at Mission Bay — San Francisco, California
View Study & Checklist ➔Phase II Study of Proton Radiation Therapy for Neuroblastoma
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
📍 University of Alabama/Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
📍 Houston Methodist Hospital — Houston, Texas
View Study & Checklist ➔Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
📍 Texas Children's Hospital — Houston, Texas
View Study & Checklist ➔Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma
📍 University of Wisconsin Carbone Cancer Center; UW Hospital and Clinics; American Family Children's Hospital — Madison, Wisconsin
View Study & Checklist ➔Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01
📍 Seattle Children's Hospital — Seattle, Washington
View Study & Checklist ➔18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔Rapid Administration Pilot for Infusing Dinutuximab
📍 Childrens Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔68Ga-DOTATATE Neuroblastoma Imaging Pilot
📍 McGill University Health Center - Children's hospital — Montreal, Quebec
View Study & Checklist ➔Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
📍 Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Neuroblastoma Biology Study
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma
📍 Texas Children's Hospital — Houston, Texas
View Study & Checklist ➔Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
📍 University of Alabama/Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
📍 Boston Children's Hospital — Boston, Massachusetts
View Study & Checklist ➔Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
📍 Connecticut Children's Medical Center — Hartford, Connecticut
View Study & Checklist ➔Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
📍 Emory - Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
📍 Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
View Study & Checklist ➔A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
📍 Memorial Sloan Kettering at Basking Ridge (Consent only) — Basking Ridge, New Jersey
View Study & Checklist ➔Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
📍 Arkansas Children's Hospital — Little Rock, Arkansas
View Study & Checklist ➔Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
📍 University of Alabama/Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
📍 University of Alabama/Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
📍 Children's Hospital of Alabama/UAB — Birmingham, Alabama
View Study & Checklist ➔